Dupont Capital Management’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Dupont Capital Management’s Portfolio SGNT Stock Details SGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-21,652	Closed	-$332K	–	712
2015 Q3	$332K	Hold	21,652	–	–	0.01%	561
2015 Q2	$526K	Buy	+21,652	New	+$519K	0.01%	511
2015 Q1	–	Sell	-41,400	Closed	-$1.04M	–	657
2014 Q4	$1.04M	Buy	+41,400	New	+$1.21M	0.02%	472
2014 Q2	–	Sell	-38,602	Closed	-$902K	–	714
2014 Q1	$902K	Sell	38,602 -39,217	-50%	-$858K	0.01%	524
2013 Q4	$1.98M	Sell	77,819 -12,054	-13%	-$272K	0.03%	360
2013 Q3	$1.83M	Buy	+89,873	New	+$2M	0.03%	391

Other funds holding SGNT

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

EAM

EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return

PCM

Penn Capital Management Philadelphia, Pennsylvania $1.58B AUM 81.2% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dupont Capital Management's SGNT Position: Q4 2015 in Review

Dupont Capital Management sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q4 2015, closing a stake of 21,652 shares — an estimated $332K sold.

Dupont Capital Management first reported a position in SGNT in Q3 2013 and held it in 6 quarters. The position peaked at $1.98M in Q4 2013. 134 funds tracked by Wall St. Rank hold SGNT as of Q4 2015.

Dupont Capital Management reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q4 2015 after selling out during the quarter.
Dupont Capital Management sold 21,652 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q4 2015, an estimated $332K.
Dupont Capital Management first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q3 2013 and held it in 6 quarters.
Dupont Capital Management's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $1.98M in Q4 2013.
134 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q4 2015.

Based on Dupont Capital Management's 13F filing for Q4 2015, filed 29 Jan 2016.